2/10/2014 4:45 PM ET|
A less stressful way to invest in Asia
This fund taps into the upside of emerging markets, while reducing some of the risk.
Emerging-markets stocks haven't been much fun lately. Over the past three years through Jan. 20, the MSCI Emerging Markets index lost an annualized 2.6 percent. True, the MSCI index -- tracked by the iShares MSCI Emerging Markets ETF (EEM) -- returned a 16.5 percent annualized gain over the past five years, but that was because the category nearly doubled over 2009 and 2010.
Investors in Matthews Asian Growth & Income (MACSX) have achieved better results with a great deal less tumult. Over the past three years through Jan. 17, the fund returned an annualized 4.9 percent -- and it also put up better numbers than the emerging-markets index over the past 10 years. During the past three years, the mutual fund (a member of the Kiplinger 25) has been 38 percent less volatile than the emerging markets index and 28 percent less wobbly than the MSCI EAFE index, which tracks foreign stocks in developed nations.
I'll admit that these comparisons may not be entirely fair. For starters, at last report the Matthews fund had 12 percent of its assets in convertible securities and 6 percent in preferred stocks, both of which are less risky than common stocks (it also had 2 percent in cash). Plus, 8 percent of the fund's stock money is in Japan and 7 percent is in Australia, which are less volatile than emerging markets. In addition, the fund's focus on dividend-paying stocks helps reduce volatility.
I wouldn't suggest that you invest all of your foreign-stock money (or even all your emerging-markets money) in Asia. About one-third of the world's emerging-markets stocks are outside the region. That said, the Asian Growth & Income fund holds a lot of appeal, both because of its record and its shock absorbers.
The fund also has an impressive pedigree: Since 1991, Matthews International Capital Management has focused on investing in Asia, and, by and large, has done it well. "If you ignore Matthews, you're making a big mistake," says William Rocco, the Morningstar analyst who covers the shop's funds. "Growth & Income has consistently been a good down-market performer and has a good long-term record."
It's a propitious time to consider Growth & Income. On average, emerging-markets stocks trade at about 11 times analysts' estimated earnings for the next 12 months. That's a steal compared with the U.S. market, which trades at about 16 times earnings.
But there's a reason that emerging markets are cheap. Developing nations in Asia and elsewhere face enormous challenges. Most important are those facing China, the world's second-largest economy (after the U.S.) and a key driver of economic growth for emerging economies everywhere and especially for those of Asian nations.
China's growth has slowed from an annual rate of more than 10 percent to about 7 percent as the country struggles to convert from an export powerhouse to one that also seeks to satisfy rising demand from Chinese consumers. In addition, Chinese banks are struggling with a large and growing number of bad loans, and the country is facing real estate bubbles in a number of areas. And China badly needs to modernize its legal and financial systems -- not to mention its political system.
But, in my view, China's problems and those facing most other Asian countries (as well as emerging markets elsewhere) are more than adequately reflected in the low stock valuations. China, for instance, trades at 10 times estimated earnings. "That's very cheap relative to its history," says Robert Horrocks, one of the Matthews fund's co-managers.
How has the fund done so well? One explanation, Horrocks says, is its long-term focus. Turnover is about 20 percent annually, suggesting that securities stay in the fund an average of five years. Horrocks and co-manager Kenneth Lowe look for companies, most of them large, with sustainable competitive advantages, the ability to boost prices, low debt and good corporate managers. The pair focus on companies that can raise their payouts, not those with the highest dividend yields. The fund's yield is a scant 0.3 percent.
In terms of sectors, the fund favors insurance, consumer-oriented banks, consumer stocks and telecom. It mostly avoids technology hardware, energy, basic materials and other more cyclical businesses. In terms of countries, the fund usually has little in India (2 percent of assets at last word), where dividends are minuscule, and it overweights Singapore (16 percent) as well as China/Hong Kong (30 percent).
On the negative side, the fund has experienced manager turnover in recent years. Paul Matthews, who founded the firm, was lead manager from 1994 to 2009. Andrew Foster was co-manager from 2005 to 2011, before leaving to launch his own firm. Horrocks has been co-manager since 2009, and Lowe joined in 2011.
The instability is worrisome. So is the recent loss of Jesper Madsen from this fund's slightly friskier sibling, Matthews Asia Dividend (MAPIX), a fine fund that's closed to new investors. Madsen co-managed Growth & Income for one year, leaving in 2011, but he was a key player at Matthews. I think, however, that Matthews has succeeded in effectively passing its strategy to the new managers. I don't expect performance to suffer.
Matthews has shown a commendable willingness to close funds before they get too big. Growth & Income, with $4.3 billion in assets, has plenty of capacity to run more money and is nowhere near closing. Annual expenses are 1.11 percent, higher than I'd like but well below the 1.78 percent average for all Asia mutual funds.
More from Kiplinger
VIDEO ON MSN MONEY
Today is already tomorrow in Asia - just call somebody that you know over there and ask them which stocks are doing well today tomorrow.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The major averages finished the session on a modestly higher note, but not before heavy selling pressure sent the Nasdaq Composite (+0.3%) for a test of its 200-day moving average. The S&P 500, meanwhile, added 0.7% with all ten sectors posting gains.
Equities climbed at the open with the advance built on the relative strength of biotechnology and other momentum names. Despite the solid early gains in those areas, the market began fading from its high as multiple ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'